NCT06977568View on ClinicalTrials.gov

A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip

PHASE2RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 25, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Osteoarthritis of Hip
Interventions
DRUG

Zilretta

triamcinolone acetonide, extended release injectable suspension

DRUG

Triamcinolone Acetonide

Triamcinolone Acetonide, Immediate Release (TCA-IR)

Trial Locations (1)

12205

RECRUITING

Medical Pain Management Services PLLC, Albany

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY